Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 18Terminated 2Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1Colonic Neoplasms 1Adenomatous Polyps 1Adenoma 1

Interventions

Cyclophosphamide 391Carboplatin 344Gemcitabine 332pembrolizumab 331Cisplatin 328Paclitaxel 298Radiotherapy 297Docetaxel 287Bevacizumab 253Rituximab 234Capecitabine 224Nivolumab 222Dexamethasone 206Fluorouracil 190fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 134Cetuximab 130fludarabine phosphate 129Bortezomib 129Lenalidomide 126Filgrastim 120Erlotinib Hydrochloride 120Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Calcium Carbonate × Clear all
NCT00470353 2023-08-04

Cholecalciferol and Calcium Carbonate in Treating Patients With Colon Cancer That Has Been Removed by Surgery

Roswell Park Cancer Institute

Phase NA Terminated
8 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00486512 2020-09-03

Chemoprevention of Colorectal Adenomas

Colotech A/S

Phase 3 Terminated
350 enrolled

Adenoma, Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡